Astera Labs (NASDAQ:ALAB) Stock Price Up 11.3% – Time to Buy?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were up 11.3% during mid-day trading on Thursday . The stock traded as high as $421.20 and last traded at $417.07. Approximately 22,491,790 shares traded hands during mid-day trading, an increase of 297% from the average daily volume of 5,663,318 shares. The stock had previously closed at $374.68.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ALAB. UBS Group initiated coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. TD Cowen increased their price target on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Stock Up 11.3%

The firm has a 50 day moving average of $252.64 and a 200 day moving average of $183.89. The firm has a market cap of $71.49 billion, a PE ratio of 281.80, a P/E/G ratio of 4.79 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the firm earned $0.33 EPS. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 28,737 shares of the company’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This represents a 0.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This represents a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161,256 shares of company stock worth $459,844,296 in the last ninety days. 10.40% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

A number of hedge funds and other institutional investors have recently bought and sold shares of ALAB. Glenmede Trust Co. NA raised its stake in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares in the last quarter. Lido Advisors LLC raised its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Perigon Wealth Management LLC raised its position in Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after purchasing an additional 73 shares in the last quarter. Clearstead Advisors LLC lifted its stake in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after purchasing an additional 76 shares during the last quarter. Finally, Sound Income Strategies LLC boosted its holdings in shares of Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.